{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:32:12Z","timestamp":1786422732095,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Embryonal rhabdomyosarcoma (ERMS) predominantly occurs in children; primary cervical ERMS in adults is exceedingly rare and readily misdiagnosed, as its typical presentations\u2014abnormal vaginal bleeding and a cervical mass\u2014closely resemble gestational trophoblastic disease and uterine sarcomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report<\/jats:title>\n                    <jats:p>We present two cases of high-grade cervical ERMS in reproductive-age women; both presented \\with abnormal vaginal bleeding and were diagnosed with stage IVB disease with regional lymph node metastasis at initial admission. Case 1 was complicated by synchronous bilateral pulmonary and multiple osseous metastases, while Case 2 exhibited a massive cervical tumor with extensive lymphatic dissemination. The two patients received distinct multimodal treatment regimens: one underwent primary surgery followed by adjuvant chemotherapy; the other received interventional embolization, neoadjuvant chemotherapy, radical resection, sequential chemoradiotherapy, and exploratory targeted maintenance therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adult cervical ERMS is highly aggressive and prone to early distant spread. Immunohistochemical markers are mandatory to confirm the rhabdomyogenic origin of this tumor. For patients with advanced disease, multimodal regimens combining neoadjuvant chemotherapy, radical resection (when surgically feasible), and adjuvant chemoradiotherapy may serve as a primary comprehensive approach to potentially prolong overall survival. In patients with actionable somatic alterations identified through comprehensive molecular profiling and formal HRD testing, individualized exploratory targeted therapy may be explored only in highly selected patients. Further clinical investigations are warranted to refine treatment strategies and improve long-term outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1856828","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:21:59Z","timestamp":1786422119000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Clinical analysis and literature review of two cases of high-grade adult-type cervical embryonal rhabdomyosarcoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Wenyu","family":"Song","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]},{"name":"Department of Obstetrics and Gynecology, Qingdao University Medical College","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejuan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0035","article-title":"Soft tissue sarcoma, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"von Mehren","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1241507","article-title":"Patient-derived organoids facilitating individual therapy in an adolescent with embryonal rhabdomyosarcoma of the cervix: A case report and literature review","volume":"13","author":"Qiao","year":"2023","journal-title":"Front Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0000000000001933","article-title":"Embryonal rhabdomyosarcoma of the uterine cervix: A clinicopathologic study of 94 cases emphasizing issues in differential diagnosis staging, and prognostic factors","volume":"46","author":"Devins","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s12905-023-02623-6","article-title":"Successful pregnancy in a female with embryonal rhabdomyosarcoma of the cervix who received biopsy and chemotherapy alone without recurrence after 16 years: A case report and literature review","volume":"23","author":"Yu","year":"2023","journal-title":"BMC Womens Health"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28601","article-title":"Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the children\u2019s oncology group, the european soft-tissue sarcoma group, and the cooperative weichteilsarkom studiengruppe","volume":"70","author":"Lautz","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010615)91:12<2454::aid-cncr1281>3.3.co;2-3","article-title":"What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract","volume":"91","author":"Arndt","year":"2001","journal-title":"Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4322\/acr.2023.419","article-title":"Embryonal rhabdomyosarcoma of the uterine cervix in an adult female","volume":"13","author":"Jadhav","year":"2023","journal-title":"Autopsy Case Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0436-0","article-title":"Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma","volume":"33","author":"de Kock","year":"2020","journal-title":"Mod Pathol"},{"key":"B9","article-title":"Advanced embryonal rhabdomyosarcoma of the uterine cervix: A case report","volume":"32","author":"Smrkolj","year":"2011","journal-title":"Eur J Gynaecol Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1999.5428","article-title":"A case of thrombopoietin-producing ovarian carcinoma confirmed by immunohistochemistry","volume":"74","author":"Furuhashi","year":"1999","journal-title":"Gynecol Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3468(85)80032-4","article-title":"Sarcomas of the vagina and uterus: The intergroup rhabdomyosarcoma study","volume":"20","author":"Hays","year":"1985","journal-title":"J Pediatr Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0b013e31826e0271","article-title":"Embryonal rhabdomyosarcoma (botryoid type) of the uterine corpus and cervix in adult women: Report of a case series and review of the literature","volume":"37","author":"Li","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0000000000001442","article-title":"Embryonal rhabdomyosarcoma of the ovary and fallopian tube: Rare neoplasms associated with germline and somatic DICER1 mutations","volume":"44","author":"McCluggage","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22913","article-title":"DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing","volume":"60","author":"Apellaniz-Ruiz","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.07.031","article-title":"Uterine sarcomas and rare uterine mesenchymal tumors with Malignant potential. Diagnostic guidelines of the french sarcoma group and the rare gynecological tumors group","volume":"167","author":"Croce","year":"2022","journal-title":"Gynecol Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12094-009-0376-0","article-title":"Embryonal rhabdomyosarcoma of the uterine cervix","volume":"11","author":"Koukourakis","year":"2009","journal-title":"Clin Transl Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.890040","article-title":"Pan-soft tissue sarcoma analysis of the incidence, survival, and metastasis: A population-based study focusing on distant metastasis and lymph node metastasis","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/17453674.2017.1293441","article-title":"The scandinavian sarcoma group central register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma","volume":"88","author":"Trovik","year":"2017","journal-title":"Acta Orthop"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-01967-9","article-title":"Analysis of clinicopathological characteristics in rhabdomyosarcoma and identification of risk factors for metastasis to the lung, bone, liver, and brain: A population-based cohort study","volume":"16","author":"Hao","year":"2025","journal-title":"Discov Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4329\/wjr.v7.i8.202","article-title":"Imaging of bone metastasis: An update","volume":"7","author":"O\u2019Sullivan","year":"2015","journal-title":"World J Radiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1186\/s12887-025-06310-3","article-title":"A case report: Pediatric rhabdomyosarcoma presenting with bone marrow metastasis","volume":"25","author":"Xiong","year":"2025","journal-title":"BMC Pediatr"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.2473","article-title":"Positron emission tomography for staging of pediatric sarcoma patients: Results of a prospective multicenter trial","volume":"25","author":"V\u00f6lker","year":"2007","journal-title":"J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-011-2221-4","article-title":"Diagnosis of bone metastases: A meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy","volume":"21","author":"Yang","year":"2011","journal-title":"Eur Radiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/8459566","article-title":"A rare case of embryonal rhabdomyosarcoma of the uterine cervix","volume":"2022","author":"Bahall","year":"2022","journal-title":"Case Rep Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/coc.0000000000000346","article-title":"Outcome after surgery for extremity soft tissue sarcoma in patients presenting with metastasis at diagnosis","volume":"41","author":"Krishnan","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880115)61:2<209::aid-cncr2820610202>3.0.co;2-l","article-title":"The intergroup rhabdomyosarcoma study-I.a final report","volume":"61","author":"Maurer","year":"1988","journal-title":"Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.01.339","article-title":"Embryonal rhabdomyosarcoma of the uterine cervix in adults: A case report and literature review","volume":"17","author":"Ditto","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-8258(03)00539-0","article-title":"Embryonal rhabdomyosarcoma of the uterine cervix: Case report and review of the literature","volume":"91","author":"Behtash","year":"2003","journal-title":"Gynecol Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2015.09.013","article-title":"Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma","volume":"34","author":"Harel","year":"2016","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.12659\/ajcr.915608","article-title":"Recurrent cervical sarcoma botryoides in a 3-year-old female: Approach in a limited resource setting","volume":"20","author":"Imawan","year":"2019","journal-title":"Am J Case Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2020.100677","article-title":"Rhabdomyosarcoma of the cervix in teenagers \u2013 is fertility preservation a feasible option","volume":"34","author":"Buruiana","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-017-4438-1","article-title":"Rhabdomyosarcoma of the lower female genital tract: An analysis of 144 cases","volume":"296","author":"Nasioudis","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01249-z","article-title":"Novel therapeutics for recurrent cervical cancer: Moving towards personalized therapy","volume":"80","author":"Cohen","year":"2020","journal-title":"Drugs"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-23-0628","article-title":"BRCAness, homologous recombination deficiencies, and synthetic lethality","volume":"83","author":"Murai","year":"2023","journal-title":"Cancer Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1856828\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:22:00Z","timestamp":1786422120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1856828\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":34,"alternative-id":["10.3389\/fonc.2026.1856828"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1856828","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"article-number":"1856828"}}